Literature DB >> 35583695

ASO Author Reflections: The Impact on Survival of Downstaging by Neoadjuvant Chemotherapy or Chemoradiotherapy in Pancreatic Adenocarcinoma.

Anne E O'Shea1, Elizabeth L Carpenter2, Daniel W Nelson3, Timothy J Vreeland2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35583695     DOI： 10.1245/s10434-022-11878-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   4.339


× No keyword cloud information.
  3 in total

1.  Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.

Authors:  Motokazu Sugimoto; Naoki Takahashi; Michael B Farnell; Thomas C Smyrk; Mark J Truty; David M Nagorney; Rory L Smoot; Suresh T Chari; Rickey E Carter; Michael L Kendrick
Journal:  J Surg Oncol       Date:  2019-08-26       Impact factor: 3.454

2.  Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial.

Authors:  Eva Versteijne; Mustafa Suker; Karin Groothuis; Janine M Akkermans-Vogelaar; Marc G Besselink; Bert A Bonsing; Jeroen Buijsen; Olivier R Busch; Geert-Jan M Creemers; Ronald M van Dam; Ferry A L M Eskens; Sebastiaan Festen; Jan Willem B de Groot; Bas Groot Koerkamp; Ignace H de Hingh; Marjolein Y V Homs; Jeanin E van Hooft; Emile D Kerver; Saskia A C Luelmo; Karen J Neelis; Joost Nuyttens; Gabriel M R M Paardekooper; Gijs A Patijn; Maurice J C van der Sangen; Judith de Vos-Geelen; Johanna W Wilmink; Aeilko H Zwinderman; Cornelis J Punt; Casper H van Eijck; Geertjan van Tienhoven
Journal:  J Clin Oncol       Date:  2020-02-27       Impact factor: 44.544

3.  Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma.

Authors:  Qiancheng Hu; Dan Wang; Ye Chen; Xiaofen Li; Peng Cao; Dan Cao
Journal:  Radiat Oncol       Date:  2019-07-10       Impact factor: 3.481
  3 in total
  1 in total

1.  ASO Author Reflections: Patient-Reported Outcomes for Breast Reconstruction Clinical Practice.

Authors:  Jacqueline J Chu; Jonas A Nelson
Journal:  Ann Surg Oncol       Date:  2022-03-18       Impact factor: 4.339
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.